What if medicine could act before symptoms appear?
Thierry Bernard, CEO of QIAGEN, joins David Berry on Averin Insights to explore how diagnostics could help healthcare move from reacting to disease toward earlier detection and more personalized care.
They discuss molecular diagnostics, AI, liquid biopsies, and predictive biology—and the work needed to turn new biological signals into useful information for patients and clinicians.
